title: Dysfunction of nodes of Ranvier: a mechanism for anti-ganglioside antibody-mediated neuropathies.
abstract: Autoantibodies against gangliosides GM1 or GD1a are associated with acute motor axonal neuropathy (AMAN) and acute motor-sensory axonal neuropathy (AMSAN), whereas antibodies to GD1b ganglioside are detected in acute sensory ataxic neuropathy (ASAN). These neuropathies have been proposed to be closely related and comprise a continuous spectrum, although the underlying mechanisms, especially for sensory nerve involvement, are still unclear. Antibodies to GM1 and GD1a have been proposed to disrupt the nodes of Ranvier in motor nerves via complement pathway. We hypothesized that the disruption of nodes of Ranvier is a common mechanism whereby various anti-ganglioside antibodies found in these neuropathies lead to nervous system dysfunction. Here, we show that the IgG monoclonal anti-GD1a/GT1b antibody injected into rat sciatic nerves caused deposition of IgG and complement products on the nodal axolemma and disrupted clusters of nodal and paranodal molecules predominantly in motor nerves, and induced early reversible motor nerve conduction block. Injection of IgG monoclonal anti-GD1b antibody induced nodal disruption predominantly in sensory nerves. In an ASAN rabbit model associated with IgG anti-GD1b antibodies, complement-mediated nodal disruption was observed predominantly in sensory nerves. In an AMAN rabbit model associated with IgG anti-GM1 antibodies, complement attack of nodes was found primarily in motor nerves, but occasionally in sensory nerves as well. Periaxonal macrophages and axonal degeneration were observed in dorsal roots from ASAN rabbits and AMAN rabbits. Thus, nodal disruption may be a common mechanism in immune-mediated neuropathies associated with autoantibodies to gangliosides GM1, GD1a, or GD1b, providing an explanation for the continuous spectrum of AMAN, AMSAN, and ASAN.
authors.affiliation: Department of Neuroscience, Baylor College of Medicine, Houston, TX 77030, USA. susuki@bcm.edu
authors.forename: Keiichiro
authors.initials: K
authors.lastname: Susuki
authors.forename: Nobuhiro
authors.initials: N
authors.lastname: Yuki
authors.forename: Dorothy P
authors.initials: DP
authors.lastname: Schafer
authors.forename: Koichi
authors.initials: K
authors.lastname: Hirata
authors.forename: Gang
authors.initials: G
authors.lastname: Zhang
authors.forename: Kei
authors.initials: K
authors.lastname: Funakoshi
authors.forename: Matthew N
authors.initials: MN
authors.lastname: Rasband
mesh_terms: D000208:Acute Disease; D000818:Animals; D000906:Antibodies / Q000009:adverse effects*; D002795:Choline O-Acetyltransferase / Q000378:metabolism; D003176:Complement C3 / Q000378:metabolism; D004195:Disease Models, Animal; D005727:Ganglia, Spinal / Q000187:drug effects / Q000378:metabolism / Q000648:ultrastructure; D005732:Gangliosides / Q000276:immunology*; D016537:Gangliosidosis, GM1 / Q000276:immunology; D007279:Injections, Subcutaneous; D046529:Microscopy, Electron, Transmission; D009431:Neural Conduction / Q000187:drug effects / Q000502:physiology; D011115:Polyneuropathies / Q000139:chemically induced* / Q000503:physiopathology; D011817:Rabbits; D011901:Ranvier's Nodes / Q000187:drug effects* / Q000378:metabolism / Q000648:ultrastructure; D051381:Rats; D017207:Rats, Sprague-Dawley; D012584:Sciatic Nerve / Q000166:cytology / Q000187:drug effects; D013049:Spectrin / Q000378:metabolism; D013116:Spinal Cord / Q000473:pathology; D018709:Statistics, Nonparametric; D013997:Time Factors
chemical_list: D000906:Antibodies; D003176:Complement C3; D005732:Gangliosides; D013049:Spectrin; C033851:ganglioside, GD1b; D002795:Choline O-Acetyltransferase